This paper provides standardized methods for histo-morphometric evaluation of the ischemic mouse heart, aiming to reduce variability and misinterpretation in preclinical testing of cardiac therapies.
Answers are grounded in this paper and cite their sources.
Standardized ischemic LV sampling may reduce histological variability in mouse MI models; extends methodological rigor for preclinical cardiac research.
Cardiac therapies are commonly tested preclinically in small-animal models of myocardial infarction. Following functional evaluation, post-mortem histological analysis is essential to assess morphological and molecular alterations underlying the effectiveness of treatment. However, non-methodical and inadequate sampling of the left ventricle often leads to misinterpretations and variability, making direct study comparisons unreliable. Protocols are provided for representative sampling of the ischemic mouse heart followed by morphometric analysis of the left ventricle. Extending the use of this sampling to other types of in situ analysis is also illustrated through the assessment of neovascularization and cellular engraftment in a cell-based therapy setting. This is of interest to the general cardiovascular research community as it details methods for standardization and simplification of histo-morphometric evaluation of emergent heart therapies.
No takes yet. Share an insight, caveat, or question.
Valente et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: